Current strategies for ischemic stroke prevention: role of multimodal combination therapies

M J Alberts1, B Ovbiagele

  • 1Dept. of Neurology, Northwestern University, Feinberg School of Medicine, 710 North Lake Shore Drive, Room 1420, Chicago, IL 60611, USA. m-alberts@northwestern.edu

Journal of Neurology
|October 16, 2007
PubMed

Insights

Stroke is a leading cause of death and disability, necessitating better treatments. Secondary stroke prevention strategies, including antiplatelet therapies, are crucial for reducing recurrent ischemic events.

Area of Science:

  • Neurology
  • Cardiology
  • Vascular Medicine

Background:

  • Stroke is a primary cause of mortality and long-term disability worldwide.
  • Ischemic strokes, often due to atherothrombosis or cardioembolism, pose significant health challenges.
  • Patients with stroke face elevated risks of recurrent ischemic events across cerebral, coronary, and peripheral vascular territories.

Purpose of the Study:

  • To emphasize the critical role of stroke prevention in managing ischemic stroke.
  • To highlight the importance of a continuum of care, initiating interventions during hospitalization and continuing outpatient management.
  • To discuss various therapeutic approaches for secondary stroke prevention.

Main Methods:

  • Review of current therapeutic strategies for secondary stroke prevention.
  • Discussion of pharmacotherapy, lifestyle adjustments, anticoagulants, and antiplatelet agents.
  • Emphasis on the integration of preventive measures within acute hospitalization and outpatient settings.

Main Results:

  • Antiplatelet therapies are fundamental to secondary stroke prevention.
  • Management of modifiable risk factors (hypertension, dyslipidemia, smoking) is essential.
  • A coordinated continuum of care is vital for preventing recurrent ischemic strokes.

Conclusions:

  • Effective stroke prevention is paramount due to limited acute treatment options.
  • Comprehensive management, including risk factor control and antiplatelet therapy, is key.
  • Initiating and maintaining preventive interventions during and after hospitalization improves patient outcomes.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...